Interestingly, ATP6V1G1 expression was also high in commercially available GBM cells (LN229 and T98G) compared to a less aggressive line (SW1088; Supplementary Figure 3A, 3B), and in high-grade human glioma tissues compared to grade II tumors (Figure 1C). The gene discussed is ATP6V1G1; the disease is glioblastoma.